← Evidence map

TrialInternational clinical psychopharmacology2026

Long-term safety and tolerability of lumateperone 42 mg in patients with bipolar disorder: results from a 6-month open-label extension study.

Mauricio Tohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40662488